In PSMA cancer management PSMA-targeted RGS provides a complementary value to SLN-RGS procedures, allowing targeting of both macro- and micro-metastases [6], concepts that rely heavily on the DROP-IN design. The gene discussed is FOLH1; the disease is cancer.